Increased Risk of Non-alcoholic Fatty Liver Disease in Low Birth Weight Individuals
- Sponsor
- Steno Diabetes Center Copenhagen
- Study ID
- NCT05890365
- Status
- Recruiting
Conditions
- Low Birth Weight
- Non-Alcoholic Fatty Liver Disease
Eligibility Criteria
- Sex
- ALL
- Age
- 34 Years - 49 Years
- Healthy Volunteers
- Not accepted
Study Details
The investigators recently demonstrated a increase in liver fat in early middle-aged LBW compared to normal birth weight (NBW) men, and 20% of the LBW - but none of the normal birth weight (NBW) - men had previously unknown non-alcoholic fatty liver disease (NAFLD). Here the investigators will further examine the Increased risk of non-alcoholic fatty liver disease in low birth weight individuals by performing a validation study.
Key Dates
- First listed
- Jun 6, 2023
- Start date
- Dec 14, 2023
- Status verified
- Apr 2026
- Primary completion
- Jun 30, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 300 participants (estimated)
Primary Outcome Measure
Liver fat content [ Time Frame: 0 minutes ]
Central Contacts
- Charlotte Brøns, PhD+4526129093
Related Studies
- SGLT2 Inhibitors as a Novel Treatment for Pediatric Non-Alcoholic Fatty Liver DiseasePHASE2 · Not Yet Recruiting · Justin Ryder · Chicago, Illinois
- Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)PHASE2 · Recruiting · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Bethesda, Maryland
- The Olmsted NAFLD Epidemiology Study (TONES)Recruiting · Mayo Clinic · Rochester, Minnesota
- AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)Recruiting · AdventHealth Translational Research Institute · Orlando, Florida